Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jordan

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Antiviral Research|June 22, 2019
Anti-HBV activity of retinoid drugs in vitro versus in vivoGabriel Birkus, Chelsea Snyder, Robert Jordan, et al.
Women'S Health (London, England)|May 17, 2016
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trialAnita H Clayton, Stanley E Althof, Sheryl Kingsberg, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2008
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitorRobert Jordan, Deborah Tien, Tove' C Bolken, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 7, 2023
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye DiseaseDavid Evans, Kenneth Kenyon, George Ousler, et al.
Antiviral Research|December 22, 2012
Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®Élida Santos-Fernandes, Cristiana O Beltrame, Chelsea M Byrd, et al.
Antiviral Therapy|February 5, 2008
Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft culturesSophie Duraffour, Robert Snoeck, Rita de Vos, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2007
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infectionElena Sbrana, Robert Jordan, Dennis E Hruby, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion proteinDharmaraj Samuel, Weimei Xing, Anita Niedziela-Majka, et al.
Antiviral Therapy|February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessMichel Perron, Kirsten Stray, April Kinkade, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Antiviral Research|June 22, 2019
Anti-HBV activity of retinoid drugs in vitro versus in vivoGabriel Birkus, Chelsea Snyder, Robert Jordan, et al.
Women'S Health (London, England)|May 17, 2016
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trialAnita H Clayton, Stanley E Althof, Sheryl Kingsberg, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2008
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitorRobert Jordan, Deborah Tien, Tove' C Bolken, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 7, 2023
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye DiseaseDavid Evans, Kenneth Kenyon, George Ousler, et al.
Antiviral Research|December 22, 2012
Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®Élida Santos-Fernandes, Cristiana O Beltrame, Chelsea M Byrd, et al.
Antiviral Therapy|February 5, 2008
Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft culturesSophie Duraffour, Robert Snoeck, Rita de Vos, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2007
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infectionElena Sbrana, Robert Jordan, Dennis E Hruby, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion proteinDharmaraj Samuel, Weimei Xing, Anita Niedziela-Majka, et al.
Antiviral Therapy|February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differentlySophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessMichel Perron, Kirsten Stray, April Kinkade, et al.
Pageof 15